November, 2024

2024 – Our group publishes in Nucleic Acids Research on the mitochondrial translation factor TACO1

2024 – Our group publishes in Nucleic Acids Research on the mitochondrial translation factor TACO1

We are excited to share that our group has published an article in Nucleic Acids Research about TACO1, a mitochondrial protein linked to a form of Leigh syndrome. In this study, led by Dr. Michele Brischigliaro as the first author, we describe TACO1’s role in facilitating mitochondrial translation by alleviating mitoribosome stalling during the synthesis […]

Read More →

Read More →

2024 – Michele receives a development grant from the Muscular Dystrophy Association (MDA)

2024 – Michele receives a development grant from the Muscular Dystrophy Association (MDA)

Dr. Michele Brischigliaro has been awarded a Development Grant from the Muscular Dystrophy Association (MDA) to investigate the role of aberrant mt-mRNA folding in mitochondrial encephalomyopathies. This well-deserved recognition highlights Michele’s innovative research and marks an important milestone on his journey toward establishing an independent scientific career. Congratulations, Michele, on this remarkable achievement!

Read More →

Read More →

2024 – Our group, in collaboration with Harvard Medical School, publishes a study in Science on the mitochondrial mRNA structurome

2024 – Our group, in collaboration with Harvard Medical School, publishes a study in Science on the mitochondrial mRNA structurome

Our group, with Dr. Conor Moran as the first author, has published a collaborative study with Harvard that advances our understanding of mitochondrial mRNA structure. This research underscores the critical role of maintaining mitochondrial mRNA folding, demonstrated using a cell line deficient in the leucine-rich pentatricopeptide repeat–containing protein (LRPPRC). LRPPRC acts as a holdase, stabilizing […]

Read More →

Read More →

Top